Skip to main content
. 2021 Nov 9;31(6):536–543. doi: 10.4103/ijn.IJN_411_19

Table 5b.

Follow up of T2D patients with symptomatic UTI on the basis of recurrent UTI

Parameter EPN baseline (recurrent UTI) n=11 EPN follow up (recurrent UTI) n=11 P* EPN baseline (non recurrent) n=9 EPN follow up (non recurrent) n=9 P *
FBG (mg/dl) 260±97 244±47 0.627 235±51 186±36 0.011
Blood glucose PP 320±134 300±37 0.638 297±57 237±46 0.025
HbA1c in % 11.7±1.8 13.1±1.2 0.044 11.8±1.6 9.0±1.2 <0.001
Creatinine (mg/dl) 2.3±1.6 2.2±1.5 0.881 1.7±0.5 1.2±0.5 0.049
eGFR (ml/min/1.73m2) 38.4±25.5 43.1±21.1 0.618 46.2±15.0 59.5±10.1 0.041
Proteinuria 9 (81.8) 4 (36.4) 0.034 3 (33.3) 0 (0) 0.065
Bacteriuria 11 (100) 3 (27.3) < 0.001 7 (77.8) 1 (11.1) 0.005
Pyuria 11 (100) 3 (27.3) < 0.001 8 (88.9) 1 (11.1) 0.001
Glycosuria 11 (100) 4 (36.4) 0.002 8 (88.9) 3 (33.3) 0.018
Organism
E. coli 10 (90.9) 3 (27.3) 6 (66.7) 1 (11.1)
 Other 0 (0) 0 (0) 2 (22.2) 0 (0)

Categorical variables [n (%)]and Continuous variables [mean±SD]. *P<0.05 is considered statistically significant. FBG-fasting blood glucose, PP-post prandial, HbA1c-glycosylated hemoglobin, eGFR-estimated glomerular filtration rate